Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer

scientific article published on 12 April 2006

Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/ANNONC/MDL080
P698PubMed publication ID16611646

P50authorRenato TalaminiQ16122860
Francesca BraviQ43131200
Silvia FranceschiQ56417107
Cristina BosettiQ67435054
Carlo La VecchiaQ2939207
P2093author name stringM Montella
E Negri
L Scotti
P2860cites workReliability of personal interview data in a hospital-based case-control studyQ30560263
Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controlsQ30659182
International trends and patterns of prostate cancer incidence and mortalityQ33882638
Statins and prostate cancer risk: a case-control studyQ34433638
Cholesterol and prostate cancerQ35613231
Prostate cancer and coronary heart disease: correlation or coincidence?Q35763063
History of diabetes mellitus and risk of prostate cancer in physiciansQ35765210
Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II.Q35977208
The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary reportQ36119639
Statin use and cancer risk in the General Practice Research DatabaseQ36694570
Case-control studies using other diseases as controls: problems of excluding exposure-related diseasesQ39635256
Statin use and the risk of breast and prostate cancerQ43966555
Blood pressure and heart rate: no evidence for a positive association with prostate cancer.Q45936337
Heart disease risk factors, diabetes, and prostatic cancer in an adult community.Q45942773
Obesity before age 30 years and risk of advanced prostate cancerQ46492944
Diet, nutrition, and prostate cancerQ47611349
Positive association between resting pulse and cancer incidence in current and former smokers.Q50538874
Reduced risk of prostate cancer among patients with diabetes mellitus.Q52945076
Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasiaQ57560034
Diabetes Mellitus and the Risk of Prostate Cancer in ItalyQ57560050
Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US MenQ57570345
P433issue6
P921main subjectprostate cancerQ181257
hypercholesterolemiaQ762713
P304page(s)1014-1017
P577publication date2006-04-12
P1433published inAnnals of OncologyQ326122
P1476titleSelf-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer
P478volume17

Reverse relations

cites work (P2860)
Q34060554A Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring
Q41460209A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer
Q28076622A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients
Q53090197Anti-Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia.
Q37665683Association between gallbladder stone disease and prostate cancer: A nationwide population-based study
Q34418735Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort
Q89975475Association of Cholecystectomy with the Risk of Prostate Cancer in Patients with Gallstones
Q42371605BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people
Q57307183Blood lipid levels and prostate cancer risk; a cohort study
Q39600769Chinese red yeast rice inhibition of prostate tumor growth in SCID mice
Q36106400Cholesterol and prostate cancer risk: a long-term prospective cohort study
Q34133206Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up
Q36717492Cholesterol, statins and cancer
Q43457233Dietary fat and early-onset prostate cancer risk
Q41090217Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling
Q42045919Ezetimibe is an inhibitor of tumor angiogenesis
Q46682007High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States
Q38414609Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation Therapy
Q39733982Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.
Q39549404Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells.
Q37547305Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer
Q37071188New developments in medulloblastoma treatment: the potential of a cyclopamine-lovastatin combination
Q44917762Onion and garlic intake and the odds of benign prostatic hyperplasia
Q85111035Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
Q58813397Prostate cancer risk in the Swedish AMORIS study
Q34158413Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Q36584255Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses
Q36293122Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy.
Q36407365Serum total and HDL cholesterol and risk of prostate cancer
Q37187362Statins and prostate cancer prevention: where we are now, and future directions.
Q28070244Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging
Q40649810The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence.
Q36686183Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes

Search more.